1. TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (N.A.M., R.P.G., J.-G.P., M.S.S.).
2. Amgen, Thousand Oaks, CA (A.R.).
3. National Heart and Lung Institute, Imperial College London, United Kingdom (P.S.S.).
4. Sydney Medical School, National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Australia (A.C.K.).